Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.00
02.04.24
-
02.04.25
0.91%
14.04.24

Risky Investment
buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.90
02.04.24
-
02.04.25
-4.70%
13.04.24

Very good company culture
Could be worthwhile Investment >10% per year
Few uniques
buy
Ocean Biomedical Inc.

Start price
Target price
Perf. (%)
€3.26
02.04.24
€7.08
02.04.25
-60.43%
02.05.24

Could be very worthwhile Investment >20% year
buy
Ionos Group SE

Start price
Target price
Perf. (%)
€23.55
02.04.24
€66.00
02.04.25
1.49%
13.04.24

Could be worthwhile Investment >10% per year
Fair valuation
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
Msp Recovery Inc.

Start price
Target price
Perf. (%)
€1.05
01.04.24
€1.50
01.04.25
66.67%
08.04.24

Capable Management
Could be worthwhile Investment >10% per year
Good culture
Few uniques
buy
Qingdao Haier Co., Ltd

Start price
Target price
Perf. (%)
€1.31
30.03.24
€1.00
30.04.24
18.70%
01.05.24

Could be very worthwhile Investment >20% year
buy
Newmont Corp.

Start price
Target price
Perf. (%)
€33.80
29.03.24
€34.00
29.03.25
9.47%
08.04.24

Standard Investments for future growth
Capable Management
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Virgin Galactic Holdings Inc.

Start price
Target price
Perf. (%)
€1.28
26.03.24
-
26.03.25
-1.07%
02.04.24

Growths much faster than the competition
Could be very worthwhile Investment >20% year
Sustainability is very important
Revenue growth > 30% per year expected
buy
Virgin Galactic Holdings Inc.

Start price
Target price
Perf. (%)
€0.95
26.03.24
-
-
26.03.24

Growths much faster than the competition
Could be very worthwhile Investment >20% year
Sustainability is very important
Revenue growth > 30% per year expected
buy
Virgin Galactic Holdings Inc.

Start price
Target price
Perf. (%)
€1.31
26.03.24
-
25.03.25
-2.30%
26.03.24

Growths much faster than the competition
Could be very worthwhile Investment >20% year
Sustainability is very important
Revenue growth > 30% per year expected
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.20
25.03.24
€4.00
31.05.26
-6.07%
07.04.24

Could be very worthwhile Investment >20% year
Virgin Galactic Holdings Inc.

Start price
Target price
Perf. (%)
€1.24
25.03.24
-
25.03.25
5.67%
26.03.24

Growths much faster than the competition
Could be very worthwhile Investment >20% year
Sustainability is very important
Revenue growth > 30% per year expected
Ocugen Inc.

Start price
Target price
Perf. (%)
€1.76
25.03.24
-
25.03.25
-13.36%
31.03.24

Risky Investment
Cannovum Cannabis AG

Start price
Target price
Perf. (%)
€5.70
25.03.24
-
25.03.25
-24.91%
31.03.24

Risky Investment
Cannovum Cannabis AG

Start price
Target price
Perf. (%)
€4.28
22.03.24
-
22.03.25
0.00%
30.03.24

Probably not worthwhile Investment
Nova Lifestyle Inc.

Start price
Target price
Perf. (%)
€2.96
22.03.24
-
22.03.25
-8.11%
30.03.24

Good culture
Risky Investment
No Innovation
No uniques
buy
Kokusai Electric Corp.

Start price
Target price
Perf. (%)
€23.14
22.03.24
€30.00
25.03.25
18.41%
30.03.24

buy
Affirm Hldgs Inc

Start price
Target price
Perf. (%)
€31.20
19.03.24
€40.00
19.03.25
3.27%
30.03.24

EBIT growth >5% per year expected
Standard Investments for future growth
Some uniques
Revenue growth > 30% per year expected
buy
Ocean Biomedical Inc.

Start price
Target price
Perf. (%)
€3.70
18.03.24
€7.40
18.03.25
-11.89%
02.04.24

Could be very worthwhile Investment >20% year
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€8.51
18.03.24
-
18.03.25
29.26%
29.03.24

Risky Investment
buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€2.84
17.03.24
-
17.03.25
14.44%
30.03.24

Could be very worthwhile Investment >20% year
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
17.03.24
€3.00
31.01.26
60.34%
25.03.24

Could be very worthwhile Investment >20% year
buy
Anixa Biosciences Inc.

Start price
Target price
Perf. (%)
€3.38
16.03.24
€6.00
16.03.25
-5.92%
30.03.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Wimi Hologram Cloud Inc.

Start price
Target price
Perf. (%)
€1.65
15.03.24
-
15.03.25
-2.42%
15.03.24

Risky Investment
Veritone Inc

Start price
Target price
Perf. (%)
€2.91
15.03.24
-
15.03.25
29.73%
15.03.24

Risky Investment